AJP - Regulatory, Integrative and Comparative Physiology, Vol 272, Issue 5 1606-R1612, Copyright © 1997 by American Physiological Society

ARTICLES

Canine adrenal catecholamine response to VIP is blocked by PACAP-(6-27) in vivo

R. Gaspo, L. Lamarche, J. de Champlain and N. Yamaguchi
Groupe de Recherche sur le Systeme Nerveux Autonome, Faculty of Pharmacy, Universite de Montreal, Quebec, Canada.

The goal of the present study was to characterize the adrenal catecholamine response to exogenous vasoactive intestinal peptide (VIP) in anesthetized dogs. We studied the potential involvement of mechanism(s) mediated by muscarinic receptors, L-type Ca2+ channels, VIP-ergic receptors, or pituitary adenylate cyclase-activating peptide (PACAP) receptors. The study consisted of five groups: a vehicle control group receiving VIP (5 micrograms) in the presence of saline and four drug-treated groups receiving VIP (5 micrograms) in the presence of either atropine (500 micrograms), nifedipine (50 micrograms), [Lys1,Pro2,5,Arg3,4,Tyr6]VIP (50 micrograms), or PACAP-(6-27) (50 micrograms). All drugs were locally infused to the left adrenal gland. Plasma catecholamine concentrations were measured in adrenal venous and aortic blood by a high-pressure liquid chromatography-electrochemical method. In the control group, VIP produced a significant increase in adrenal catecholamine output. Neither atropine, nifedipine, nor[Lys1,Pro2,5,Arg3,4,Tyr6]-VIP significantly affected the medullary response to VIP. In the presence of PACAP-(6-27), however, the catecholamine response to VIP was attenuated by approximately 77% (P < 0.05). The present study suggests that adrenal catecholamine secretion induced by exogenous VIP may be mediated by a PACAP-related mechanism, most probably through a PACAP type I receptor, in anesthetized dogs. The data also indicate that neither muscarinic receptors, VIP-ergic receptors, nor dihydropyridine-sensitive L-type Ca2+ channels are operative in the adrenal catecholamine response to exogenous VIP in vivo.

This article has been cited by other articles:

				Y. Fukushima, H. Hikichi, K. Mizukami, T. Nagayama, M. Yoshida, M. Suzuki-Kusaba, H. Hisa, T. Kimura, and S. Satoh Role of endogenous PACAP in catecholamine secretion from the rat adrenal gland Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1562 - R1567. [Abstract] [Full Text] [PDF]

				S. Lamouche and N. Yamaguchi Role of PAC1 receptor in adrenal catecholamine secretion induced by PACAP and VIP in vivo Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2001; 280(2): R510 - R518. [Abstract] [Full Text] [PDF]

				D. Vaudry, B. J. Gonzalez, M. Basille, L. Yon, A. Fournier, and H. Vaudry Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: From Structure to Functions Pharmacol. Rev., June 1, 2000; 52(2): 269 - 324. [Abstract] [Full Text] [PDF]

				G. Geng, R. Gaspo, F. Trabelsi, and N. Yamaguchi Role of L-type Ca2+ channel in PACAP-induced adrenal catecholamine release in vivo Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1997; 273(4): R1339 - R1345. [Abstract] [Full Text] [PDF]